An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A smartphone app delivering simple cognitive-behavioral skills helped significantly ease mild (subthreshold) depression, with ...

New research spotlights the habenula, a tiny but powerful brain region, as a key player in addiction, motivation, and emotional regulation.

For many people with major depression, current treatments either don’t work or take too long to show results. About one in ...

The University of Colorado Anschutz is part of a national study looking at the potential benefits and risks of psilocybin ...

A new smartphone app developed at Emory University is allowing researchers to analyze patients' voice diaries to improve their health.

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

Hutcheon called it a "gamechanger" and Hockley said it was "just a miracle". The spray will officially be listed on the PBS on Thursday, reducing the price from about $800 a week to $7.70 per dose for ...

A nasal spray based on a ketamine-related compound has been approved for use in Australia to treat patients with severe ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.